West Pharmaceutical Services, Inc. (WST)
348.30
-5.02
(-1.42%)
USD |
NYSE |
Aug 25, 16:00
348.00
-0.30
(-0.09%)
After-Hours: 19:38
West Pharmaceutical Services Cash from Operations (Quarterly) : 124.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 124.00M |
| March 31, 2026 | 89.90M |
| December 31, 2025 | 251.10M |
| September 30, 2025 | 197.20M |
| June 30, 2025 | 177.10M |
| March 31, 2025 | 129.40M |
| December 31, 2024 | 190.10M |
| September 30, 2024 | 180.10M |
| June 30, 2024 | 165.00M |
| March 31, 2024 | 118.20M |
| December 31, 2023 | 239.10M |
| September 30, 2023 | 230.10M |
| June 30, 2023 | 169.20M |
| March 31, 2023 | 138.10M |
| December 31, 2022 | 230.80M |
| September 30, 2022 | 168.90M |
| June 30, 2022 | 173.10M |
| March 31, 2022 | 151.20M |
| December 31, 2021 | 160.80M |
| September 30, 2021 | 190.10M |
| June 30, 2021 | 144.40M |
| March 31, 2021 | 88.70M |
| December 31, 2020 | 148.70M |
| September 30, 2020 | 118.60M |
| June 30, 2020 | 148.10M |
| Date | Value |
|---|---|
| March 31, 2020 | 57.10M |
| December 31, 2019 | 106.40M |
| September 30, 2019 | 108.10M |
| June 30, 2019 | 105.10M |
| March 31, 2019 | 47.60M |
| December 31, 2018 | 73.20M |
| September 30, 2018 | 88.40M |
| June 30, 2018 | 82.00M |
| March 31, 2018 | 45.00M |
| December 31, 2017 | 81.50M |
| September 30, 2017 | 75.80M |
| June 30, 2017 | 85.30M |
| March 31, 2017 | 20.70M |
| December 31, 2016 | 71.80M |
| September 30, 2016 | 68.40M |
| June 30, 2016 | 76.20M |
| March 31, 2016 | 3.00M |
| December 31, 2015 | 68.00M |
| September 30, 2015 | 68.80M |
| June 30, 2015 | 77.50M |
| March 31, 2015 | -1.90M |
| December 31, 2014 | 46.00M |
| September 30, 2014 | 63.90M |
| June 30, 2014 | 64.20M |
| March 31, 2014 | 8.80M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Globus Medical, Inc. | 209.74M |
| Hinge Health, Inc. | 101.41M |
| Baxter International, Inc. | 285.00M |
| The Cooper Cos., Inc. | 182.80M |
| Becton, Dickinson & Co. | 652.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -43.20M |
| Cash from Financing (Quarterly) | -164.80M |
| Free Cash Flow | 436.90M |
| Free Cash Flow Per Share (Quarterly) | 1.133 |
| Free Cash Flow to Equity (Quarterly) | 85.30M |
| Free Cash Flow to Firm (Quarterly) | 82.94M |
| Free Cash Flow Yield | 1.74% |